NIH recap on ‘brain disease test’: strong on study results, but lacks clarity on patient benefits
Summary of early Parkinson’s drug study claims there’s proof, but that’s misleading
Older drug retested for managing Parkinson’s disease symptoms: What are the costs and harms?
FDA release on drug for treating Parkinson’s psychosis lacks some key details
Possible new Parkinson’s drug — Novel: Yes. “Breakthrough”: No.
After false start, release on new approach to Parkinson’s treatment recovers quickly, provides context